Search results

Chloroplasts and mitochondria: functional genomics and evolution - Papers of Discussion Meetings organized and edited by J. F. Allen and J. A. Raven - Meetings held at The Royal Society on 26 and 27 June 2002 and at the Novartis Foundation on 28 June 2002 - Introduction

{2,6-bis[(diphenylphosphino)methyl]-phenyl}chloroplatinum(II)

The title compound, [PtCl(C32H27P2)], has a pseudo-square-planar coordination geometry around the Pt atom with the P,C,P'-tridentate ligand forming two five-membered rings that are tilted with respect to the coordination plane. The two Pt-P the Pt-Cl and the Pt-C distances are 2.2794 (9)/2.2749 (10), 2.3831 (10) and 2.002 (3) Angstrom, respectively.

cis-[2,6-bis(di-tert-butylphosphinomethyl)cyclohexyl-kappa P-3,C-1,P '] bromidopalladium(II)

The title compound, [PdBr(C24H49P2)], has a distorted square-planar coordination geometry with the P, C, P'-tridentate ligand forming two five-membered chelate rings. The Br atom is displaced from the square plane by 0.560 (6) angstrom.

Proceedings of the 6th workshop of ICTCT "Pedestrian problems" Prague Oct 26th - 28th 1994

Testicular-cancer survivors experience compromised language following chemotherapy: Findings in a Swedish population-based study 3-26 years after treatment

Background. Studies suggest an increased risk for compromised cognitive function among cancer survivors. It is unclear to what extent chemotherapy is the cause and how the dysfunction, when present, affects everyday life. The objective was to study self-reported behaviours that may depend on cognitive function, among testicular-cancer survivors who received various cycles of cisplatin-based chemot

Extremely high viral loads of HPV26 and HPV88 in squamous cell carcinomas (SCC) of the nail unit in an HIV-immunosuppressed patient

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.

Accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet No. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelin

A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1

Workshop on Feedback and Synthesis of Linear Systems, Bielefeld, Germany, June 22-26, 1981

t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene

Natural Radiative Lifetimes and Hyperfine-structure of the 4s^(2)6p^(2p)_(3/2,1/2) Levels of Gallium

NADH electrocatalytic oxidation at 2,6-dichlorophenolindophenol modified electrodes

Predictors of failure to rescue after fenestrated-branched endovascular aortic repair of thoracoabdominal aortic aneurysms: Presented at the Thirty-seventh Annual Meeting of the European Society of Vascular Surgery, Belfast, Northern Ireland, September 26-29, 2023

RIFM fragrance ingredient safety assessment, 3,7-dimethyl-2,6-nonadienenitrile, CAS Registry Number 61792-11-8

Report of Lund University Center for Middle Eastern Studies' Visit to Hungary, 25-26 May 2017

Severe fetal growth restriction at 26–32 weeks : key messages from the TRUFFLE study

Reaching Beyond your Base? Incumbent and Opposition Party Nationalization in 26 Sub-Saharan African States

Partnering to change the world for people with haemophilia : 6^th Haemophilia Global Summit, Prague, Czech Republic, 24–26^th September 2015

The 6th Haemophilia Global Summit was held in Prague, Czech Republic, in September 2015. The programme was designed by an independent Scientific Steering Committee of haemophilia experts and aimed to share optimal management strategies for haemophilia at all life stages, explore recent potential advances in the management of haemophilia A and B and discuss challenges in haemophilia care. In this s

RIFM fragrance ingredient safety assessment, 2-methylundecanol, CAS Registry Number 10522-26-6

This material was evaluated for genotoxicity, repeated dose toxicity, reproductive toxicity, local respiratory toxicity, phototoxicity/photoallergenicity, skin sensitization, as well as environmental safety. Data from the suitable read across analogs 2-butyloctan-1-ol (CAS # 3913-02-8) and 2-ethyl-1-hexanol (CAS # 104-76-7) show that this material is not genotoxic nor does it have skin sensitizati

Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia